View Item 

Show simple item record

An intragenic Taq I polymorphism in the faciogenital dysplasia (FGD1) locus, the gene responsible for Aarskog syndrome
dc.contributor.authorPasteris, N. Germanen_US
dc.contributor.authorGorski, Jerome L.en_US
dc.date.accessioned2006-09-11T19:13:29Z
dc.date.available2006-09-11T19:13:29Z
dc.date.issued1995-10en_US
dc.identifier.citationPasteris, N. German; Gorski, Jerome L.; (1995). "An intragenic Taq I polymorphism in the faciogenital dysplasia (FGD1) locus, the gene responsible for Aarskog syndrome." Human Genetics 96(4): 494-494. <http://hdl.handle.net/2027.42/47642>en_US
dc.identifier.issn0340-6717en_US
dc.identifier.issn1432-1203en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/47642
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7557980&dopt=citationen_US
dc.description.abstractA Taq I polymorphism, located in intron 4 of the faciogenital dysplasia ( FGD1 ) gene, the gene responsible for Aarskog syndrome, is described. FGD1 encodes a putative Rho/Rac guanine nucleotide exchange factor involved in mammalian morphogenesis. The identification of an intragenic polymorphism will facilitate the accurate carrier detection of individuals at risk for Aarskog syndrome.en_US
dc.format.extent99355 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherHuman Geneticsen_US
dc.subject.otherMolecular Medicineen_US
dc.subject.otherMetabolic Diseasesen_US
dc.subject.otherInternal Medicineen_US
dc.subject.otherBiomedicineen_US
dc.titleAn intragenic Taq I polymorphism in the faciogenital dysplasia (FGD1) locus, the gene responsible for Aarskog syndromeen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbsecondlevelGeneticsen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Human Genetics and Pediatrics and Communicable Diseases, University of Michigan Medical Center, 48109-0688, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Human Genetics and Pediatrics and Communicable Diseases, University of Michigan Medical Center, 48109-0688, Ann Arbor, MI, USA; Pediatrics and Communicable Diseases, Division of Pediatric Genetics, University of Michigan Medical Center, 48109-0688, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid7557980en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/47642/1/439_2004_Article_BF00191816.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00191816en_US
dc.identifier.sourceHuman Geneticsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
439_2004_Article_BF00191816.pdf
Size:
97.02KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.